. 2023 Feb 16;2023(2):CD014758. doi: 10.1002/14651858.CD014758.pub2

007450.

Study name	Atropine eye drops to decrease myopia progression in children
Methods	Randomised parallel‐group design
Participants	Inclusion criteria: 40 children aged 6‐12 years; SER error between −2 D and −6 D in each eye; distance vision correctable to logMAR 0.2 or better in both eyes; normal ocular health other than myopia; informed consent; willingness to follow up Exclusion criteria: astigmatism > −1.5 D; amblyopia; strabismus; allergy to atropine or homatropine; previous or concurrent use of contact lenses, BFs, PALs or other forms of treatment for myopia; history of cardiac, neurological, or significant respiratory disease; unwillingness to give consent/follow‐up
Interventions	Intervention 1: 0.01% atropine eye drop Comparison intervention: 0.5% carboxymethylcellulose eye drop
Outcomes	Primary outcome: myopia progression Secondary outcomes: AEs Maximum follow‐up: 1 year
Starting date	January 2016 Estimated end date: not reported
Contact information	ctri.nic.in/Clinicaltrials/pdf_generate.php?trialid=15817&EncHid=&modid=&compid=%27,%2715817det%27
Notes